Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IceCure Medical (ICCM) Shares Outstanding (Weighted Average) (2020 - 2025)

Historic Shares Outstanding (Weighted Average) for IceCure Medical (ICCM) over the last 6 years, with Q3 2025 value amounting to $180.0.

  • IceCure Medical's Shares Outstanding (Weighted Average) fell 1818.18% to $180.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $180.0, marking a year-over-year decrease of 1818.18%. This contributed to the annual value of $300.0 for FY2024, which is 625.0% down from last year.
  • According to the latest figures from Q3 2025, IceCure Medical's Shares Outstanding (Weighted Average) is $180.0, which was down 1818.18% from $120.0 recorded in Q2 2025.
  • Over the past 5 years, IceCure Medical's Shares Outstanding (Weighted Average) peaked at $37.0 million during Q4 2022, and registered a low of $60.0 during Q1 2025.
  • For the 5-year period, IceCure Medical's Shares Outstanding (Weighted Average) averaged around $3.5 million, with its median value being $180.0 (2025).
  • In the last 5 years, IceCure Medical's Shares Outstanding (Weighted Average) skyrocketed by 7142.86% in 2022 and then plummeted by 9999.91% in 2023.
  • Over the past 5 years, IceCure Medical's Shares Outstanding (Weighted Average) (Quarter) stood at $28.5 million in 2021, then increased by 29.66% to $37.0 million in 2022, then tumbled by 100.0% to $320.0 in 2023, then dropped by 6.25% to $300.0 in 2024, then plummeted by 40.0% to $180.0 in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $180.0 for Q3 2025, versus $120.0 for Q2 2025 and $60.0 for Q1 2025.